GC Biopharma breaks into Malaysia’s plasma fractionation market
GC Biopharma has won its first-ever government contract in Malaysia for plasma-derived products, marking the first time a…
GC Biopharma
4 개의 기사가 있습니다.
Hanmi and GC Biopharma Begin Fabry Disease Trials in Korea
Hanmi Pharmaceutical and GC Biopharma are set to begin clinical trials in Korea for their Fabry disease treatment,…
Will GC Biopharma's Immune Globulin 'Alyglo' Succeed in the U.S. Market?
GC Biopharma Corp's new immune globulin drug 'Alyglo' is set to enter the U.S. market after 8 years…
GC Biopharma's ALYGLO Signs Contract with Major U.S. PBM
GC Biopharma announced on the 2nd that it has signed a contract with a major Pharmacy Benefit Manager…